Earnings Feed
Start Free
Home/Insiders/BEST LAWRENCE C
BL
SEC Insider//CIK 0001191248

BEST LAWRENCE C

CIK 00011912484 companiesSALT LAKE CITY, UT
SEC Profile

Transactions

50

Companies

4

Filings

15

CIK

0001191248

Recent Transactions

50 trades
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2019-12-05+11,687→ 60,790 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2018-11-29+9,360→ 49,103 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2017-11-30+7,219→ 39,743 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2016-12-01+15,024→ 32,524 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2015-12-03+7,500→ 17,500 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2014-12-04+10,000→ 10,000 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2013-12-05+30,000→ 30,000 total
  • Award
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2013-07-24+6,573→ 6,573 total
  • Award
    HAEMONETICS CORP$HAE

    Common Stock

    2013-07-24+1,649→ 10,001 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Common Stock

    2013-05-03$26.38/sh+12,000→ 20,352 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2013-05-03$38.32/sh−12,000→ 8,352 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2013-05-03−12,000→ 0 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2012-12-05+30,000→ 30,000 total
  • Award
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2012-07-27+4,098→ 4,098 total
  • Award
    HAEMONETICS CORP$HAE

    Common Stock

    2012-07-27$0.01/sh+1,031→ 4,176 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2011-12-02+30,000→ 30,000 total
  • Award
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2011-07-21$68.81/sh+3,559→ 3,559 total
  • Award
    HAEMONETICS CORP$HAE

    Common Stock

    2011-07-21$0.01/sh+944→ 3,145 total
  • Disposition to Issuer
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2011-06-07$24.58/sh−100,000→ 0 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$61.65/sh−6,000→ 2,201 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$44.74/sh+6,000→ 8,201 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$61.94/sh−6,000→ 2,201 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Non-Qualifed Stock Option (right to buy)

    2011-02-07$61.65/sh−6,000→ 0 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$26.11/sh+6,000→ 8,201 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2011-02-07$62.00/sh−4,695→ 0 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2011-02-07$61.94/sh−6,000→ 0 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$20.46/sh+4,695→ 6,896 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-07$62.00/sh−4,695→ 2,201 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2011-02-04$61.06/sh−15,305→ 4,695 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-04$61.06/sh−15,305→ 2,201 total
  • Exercise/Conversion
    HAEMONETICS CORP$HAE

    Common Stock

    2011-02-04$20.46/sh+15,305→ 17,506 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2010-12-03+30,000→ 30,000 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2010-12-01$21.55/sh−65,000→ 100,000 total
  • Sale
    MYRIAD GENETICS INC$MYGN

    Common Stock

    2010-11-30$21.49/sh−25,000→ 165,000 total
  • Award
    HAEMONETICS CORP$HAE

    Common Stock

    2010-07-29$0.01/sh+1,193→ 2,201 total
  • Award
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2010-07-29+4,290→ 4,290 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2010-02-18$53.42/sh−50,000→ 1,008 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2010-02-17$53.63/sh−25,000→ 51,008 total
  • Sale
    HAEMONETICS CORP$HAE

    Common Stock

    2010-02-16$53.51/sh−25,000→ 76,008 total
  • Award
    MYRIAD GENETICS INC$MYGN

    Non-Qualified Stock Option (right to buy)

    2009-09-16+30,000→ 30,000 total
  • Award
    HAEMONETICS CORP$HAE

    Common Stock

    2009-07-30$0.01/sh+367→ 101,008 total
  • Award
    HAEMONETICS CORP$HAE

    Non-Qualified Stock Option (right to buy)

    2009-07-30+5,879→ 5,879 total
  • Award
    BIOGEN INC.$BIIB

    Common Stock

    2008-06-19+2,050→ 5,600 total
  • Award
    BIOGEN INC.$BIIB

    Stock Option (rignt to buy)

    2008-06-19+5,700→ 5,700 total
  • Exercise/Conversion
    BOSTON SCIENTIFIC CORP$BSX

    Common Stock

    2007-07-01+10,000→ 242,189 total
  • Exercise/Conversion
    BOSTON SCIENTIFIC CORP$BSX

    Deferred Stock Units

    2007-07-01−10,000→ 67,200 total
  • Tax Payment
    BOSTON SCIENTIFIC CORP$BSX

    Common Stock

    2007-07-01$15.48/sh−4,175→ 238,014 total
  • Award
    BIOGEN INC.$BIIB

    Stock Option (right to buy)

    2007-05-31+5,950→ 5,950 total
  • Award
    BIOGEN INC.$BIIB

    Common Stock

    2007-05-31+2,300→ 3,550 total
  • Exercise/Conversion
    BIOGEN INC.$BIIB

    Common Stock

    2007-05-25+1,250→ 1,250 total

Companies

4

Recent Filings

15

Address

320 WAKARA WAY

SALT LAKE CITY, UT, 84108

View on SEC.gov